To test this, we used flow cytometry to compare the T-bet-expressing frequencies in peripheral blood Th17.0 (RORγt+CCR6+CCR4+CXCR3−) cells between sarcoidosis subjects with different clinical trajectories defined by longitudinal changes in lung function and immunosuppression use. The gene discussed is CXCR3; the disease is sarcoidosis.